Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06368687
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-11
Brief Title:
TRANPAS - TReating Anorexia Nervosa Plus Autism Spectrum
Sponsor:
Göteborg University
Organization:
Göteborg University
Study Overview
Official Title:
Anorexia Nervosa and Autism - a Care Location Adapted for Both Conditions
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRANPAS
Brief Summary:
In a pilot study we will validate a so-called autism care location in an inpatient ward The care location will be adapted for patients with anorexia nervosa AN and concurrent autism ANautism In order to investigate the effect of a tailored care location for patients with AN autism the evaluation will include weight development and changes in nutritional intake eating disorder and anxiety symptoms The overall aim is to improve treatment for this specific AN subgroup that otherwise has a worse prognosis regarding AN recovery
Detailed Description:
Anorexia nervosa AN is a serious eating disorder and has the highest mortality rate of all psychiatric illnesses Adolescence is the most common age of onset Nine out of ten people who fall ill are girlswomen and 2 of all girlswomen will fall ill with AN at some point in their lives In AN one engages in self-starvation which in turn leads to underweight 75 - 80 of individuals with AN recover during adolescence while the remainder are at high risk of developing chronic AN For the individual the chronic condition means great suffering in the form of serious psychiatric and somatic co-morbidity social isolation and reducedlack of work ability People with autism show social withdrawal and reduced flexibility reminiscent of the symptoms seen in AN An estimated 15 - 20 of all individuals with AN also have autism People with AN and concurrent autism run an increased risk of a worse prognosis as they have more difficulty absorbing treatment which in itself increases the risk of the condition becoming chronic Today there is no scientific evidence for how people with AN and concurrent autism should be treated
In a pilot study we will validate a so-called autism care location in our inpatient ward at Sahlgrenska University Hospital in Gothenburg Sweden The care location will be adapted for patients with AN and concurrent autism ANautism In order to investigate the effect of a tailored care location for patients with AN autism the evaluation will include weight development and changes in nutritional intake eating disorder and anxiety symptoms The overall aim is to improve treatment for this specific AN subgroup that otherwise has a worse prognosis regarding AN recovery
In a pilot study we will validate a so-called autism care location in our inpatient ward at Sahlgrenska University Hospital in Gothenburg Sweden The care location will be adapted for patients with AN and concurrent autism ANautism In order to investigate the effect of a tailored care location for patients with AN autism the evaluation will include weight development and changes in nutritional intake eating disorder and anxiety symptoms The overall aim is to improve treatment for this specific AN subgroup that otherwise has a worse prognosis regarding AN recovery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None